EP1643954A1 - Titration/compliance pack - Google Patents
Titration/compliance packInfo
- Publication number
- EP1643954A1 EP1643954A1 EP04756814A EP04756814A EP1643954A1 EP 1643954 A1 EP1643954 A1 EP 1643954A1 EP 04756814 A EP04756814 A EP 04756814A EP 04756814 A EP04756814 A EP 04756814A EP 1643954 A1 EP1643954 A1 EP 1643954A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- tablets
- sets
- different
- rows
- columns
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
- A61J1/035—Blister-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Definitions
- the present invention is generally directed to a titration package for enabling compliance with a regimen of changing dosage of medication over a period of time and is more particularly directed to a dosage pack for dosing of oral Memantine for the indication of preventing further nerve cell loss in glaucoma patients.
- Glaucoma is characterized by damaged to the optic nerve which is typically accompanied by a decrease in normal vision field.
- An early sign of possible glaucomatous visual field loss is elevated interocular pressure.
- glaucoma has typically been treated by medically and/or surgically lowering elevated interocular pressure.
- Memantine and other compounds suitable for chronic administration should be administered to avoid adverse events associated with the drug, for example, patients prescribed Memantine therapy need to be titrated upwards from 5mg of Memantine per day to a maintenance dose of either lOmg or 20mg per day.
- Memantine approved for other indications also requires similar titration schedules to avoid drug-related adverse events.
- the present invention is directed to a titration package for enabling compliance with a regimen of changing dosage of medication over a period of time and further- provides for a method of treating a human patient to reduce damage to retinal ganglion cells associated with glaucoma utilizing the titration package in accordance with the present invention.
- a titration package for enabling compliance with a regimen of changing dosage of medication over a period of time in accordance with the present invention generally includes a backing having an array of receivers with the array including a plurality of columns and a plurality of rows .
- a plurality of sets of tablets are provided in the receivers.
- Each tablet in a set has a common dose of medication and a different dose than a tablet of a different set.
- Each set of tablets is disposed in receivers of one of an adjacent row and an adjacent column.
- Indicia is provided and disposed adjacent the columns and rows for displaying common days and successive weeks.
- the package provides for a titration schedule which prevents adverse events as a result of mis-dosing.
- the package in accordance with the present invention provides for a safer and accordingly more beneficial method for enabling compliance with the regimen.
- different sets of tablets are disposed in different rows with each row being indicated by a successive week and each column being indicated as a different day of the week.
- the sets of tablets having increased doses are disposed in receivers in rows indicated as successive weeks. More specifically, the sets of tablets have 5mg, lOmg, 15mg and 20mg doses of Memantine.
- different sets of tablets are disposed in different columns, with each column being indicated as a successive week and each row being indicated as a different day of the week.
- the titration package for enabling compliance with a regimen of changing doses of medication over a period of time includes a backing having an array or receivers with the array including a plurality of columns and a plurality of rows.
- a plurality of sets of tablets are provided with each set being disposed in receivers of a plurality of adjacent rows or a plurality of adjacent columns. This plurality may be two and each tablet in a set has a common dose of medication and a different dose than a tablet in a different set.
- pairs of adjacent rows have differing sets of tablets. This enables the change of dosage over an eight-week period of time from 5mg to 20mg doses of Memantine.
- the present invention provides for a method for enabling compliance with a regimen of changing dosage of medication with the method comprising the steps of providing a backing having an array of receivers, with the array including a plurality of columns and a plurality of rows.
- the method further includes disposing a plurality of sets of tablets and the receivers with each tablet in the set having a common dose of medication and a different dose than a tablet of a different set.
- Each set is disposed in receivers of one of an adjacent row and an adjacent column.
- the method finally includes a step of providing indicia adjacent the columns and rows indicating common days and successive weeks.
- a concomitant method in accordance with the present invention provides for a method of treating a human patient to reduce damage to retinal ganglion cells associated with glaucoma with the method comprising providing a titration package for enabling compliance with a regimen of changing dosage of medication over a period of time.
- the package includes the elements hereinabove recited and further the medication comprises Memantine.
- Figure 1 is a representation of a titration package in accordance with the present invention for enabling compliance with a regimen of changing dosage of medication over a four-week period of time;
- Figure 2 is a representation of a titration package similar to that shown in Figure 1 enabling compliance with a regimen of changing dosage of medication over a period of eight weeks; and
- Figure 3 is a representation similar to the titration package shown in Figure 2 showing an alternative arrangement of days and successive weeks, as will be hereinafter described.
- the titration package and method in accordance to the present invention is particularly useful for the dosage of oral medication for infirmed and elderly patients and accordingly the manipulation of tablets enabled by the present invention and tracking of compliance with a titration schedule is a great advantage.
- a titration package 10 for enabling compliance with a regimen of changing dosage of medication over a period of time, for example four weeks with the package 10 including a backing 12 which includes an array 18 of receivers holding a plurality of sets 24, 26, 28, 30 of tablets 34, 36, 38, 40.
- the receivers 20 may be conventional, rupturable blisters as, for example, as set forth in U.S. RE29,705 which is to be incorporated herewith in its entirety for the purpose of describing the type of rupturable receivers suitable for use with the present invention.
- the backing 12 may be any suitable plastic or paperboard backing and may be incorporated into protective coverings, not shown, such as, for example, shown in U.S. Patent No. 6,047,829. This patent is to also be incorporated herewith in its entirety by this specific reference thereto for showing a backing and dispensing package construction suitable for use in the present invention.
- the array 18 of receivers 20 includes a plurality of columns indicated by the arrows 44 and a plurality of rows indicated by the arrows 46.
- Indicia 50, 52 is provided and disposed adjacent the columns 44 and rows 46, preferably on the backing 12 displays common days and successive weeks. As shown in Figure 1, different sets are disposed in different rows 46 as indicated by week 1, week 2, week 3, and week 4. The number following the indicia "week" indicating successive weeks and the columns 44 indicated as Sunday, Monday, Tuesday, Wednesday, Thursday, Friday, and Saturday indicating different days of the week.
- the set 24 includes 5mg of Memantine
- the set 26 includes tablets of lOmg of Memantine
- the set 28 includes tablets of 15mg of Memantine
- the set 30 includes tablets of 30mg of Memantine arranged in the rows 46 indicated as week 1, week 2, week 3, and week 4.
- a patient utilizing the package and method of the present invention is titrated from a 5mg dose to a 20mg dose of the Memantine.
- a patient beginning the regimen may start on any given day of the week, for example, Tuesday and progressively take the tablets by rupturing the receivers 20 along a row until all of the tablets 34 have been dispensed.
- the patient begins week 2 of the regimen by taking the tablets 36 disposed in the row 46 indicated by the indicia, week 2.
- the arrangement and dosages of the tablets therein enables compliance with the regimen of changing the dosage of the medication over the period of time, four weeks as indicated in Figure 1.
- a backing 62 is provided with an array 66 of receivers 68 with the array being arranged in rows indicated by the indicia, "week 1 - 8" and columns indicated as “Sun-Sat” .
- the titration packages 60, 100 enable compliance with a regimen of changing dosage of medication over a period of time as hereinabove described in connection with the package 10 shown in Figure 1.
- the present invention may suitably comprise, consist of, or consist essentially of the recited elements.
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/622,170 US7086532B2 (en) | 2003-07-16 | 2003-07-16 | Titration/compliance pack with increasing doses |
PCT/US2004/021991 WO2005009326A1 (en) | 2003-07-16 | 2004-07-09 | Titration/compliance pack |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1643954A1 true EP1643954A1 (en) | 2006-04-12 |
Family
ID=34063153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04756814A Withdrawn EP1643954A1 (en) | 2003-07-16 | 2004-07-09 | Titration/compliance pack |
Country Status (15)
Country | Link |
---|---|
US (3) | US7086532B2 (en) |
EP (1) | EP1643954A1 (en) |
JP (1) | JP2007531541A (en) |
KR (1) | KR20060038998A (en) |
CN (1) | CN1822808A (en) |
AU (1) | AU2004258884A1 (en) |
BR (1) | BRPI0412583A (en) |
CA (1) | CA2532438A1 (en) |
IL (1) | IL173075A0 (en) |
MX (1) | MXPA06000466A (en) |
NO (1) | NO20060083L (en) |
PL (1) | PL379123A1 (en) |
RU (1) | RU2006105657A (en) |
WO (1) | WO2005009326A1 (en) |
ZA (1) | ZA200510420B (en) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7086532B2 (en) * | 2003-07-16 | 2006-08-08 | Allergan, Inc. | Titration/compliance pack with increasing doses |
HUE034290T2 (en) | 2003-04-29 | 2018-02-28 | Orexigen Therapeutics Inc | Compositions for affecting weight loss comprising an opioid antagonist and bupropion |
WO2005109119A2 (en) | 2004-04-24 | 2005-11-17 | Inrange Systems, Inc. | Integrated, non-sequential, remote medication management and compliance system |
US7828147B2 (en) | 2004-04-24 | 2010-11-09 | Inrange Systems, Inc. | Multi-layer medication carrier |
US20070095850A1 (en) * | 2005-10-27 | 2007-05-03 | Meyer Daniel D | Multiple medication dispensing system |
CA2630624C (en) | 2005-11-22 | 2013-08-06 | Orexigen Therapeutics, Inc. | Compositions and methods for increasing insulin sensitivity |
US7909165B2 (en) * | 2006-04-10 | 2011-03-22 | Poppack, Llc | System for delivering sequential components |
US8916195B2 (en) | 2006-06-05 | 2014-12-23 | Orexigen Therapeutics, Inc. | Sustained release formulation of naltrexone |
AU2007319472B2 (en) * | 2006-11-09 | 2013-01-17 | Nalpropion Pharmaceuticals Llc | Methods Of Administering Weight Loss Medications |
EP2089005B1 (en) | 2006-11-09 | 2010-03-17 | Orexigen Therapeutics, Inc. | Layered pharmaceutical formulations comprising an intermediate rapidly dissolving layer |
AU2008298017B2 (en) * | 2007-09-12 | 2012-03-01 | Merz Pharma Gmbh & Co. Kgaa | Titration package for neramexane and its use in the treatment of an inner ear disorder |
EP2082717A1 (en) * | 2008-01-28 | 2009-07-29 | Merz Pharma GmbH & Co. KGaA | Titration package |
US20090230013A1 (en) * | 2008-03-17 | 2009-09-17 | The Procter & Gamble Company | User-Customizable Dosing System |
EP2303025A4 (en) | 2008-05-30 | 2012-07-04 | Orexigen Therapeutics Inc | Methods for treating visceral fat conditions |
US20100043255A1 (en) * | 2008-08-21 | 2010-02-25 | Trevino Steven M | External sole liner and method of manufacturing and using the same |
EP2177275A1 (en) | 2008-10-16 | 2010-04-21 | Merz Pharma GmbH & Co. KGaA | Pump dispenser for the titration of pharmaceuticals |
WO2010054202A2 (en) * | 2008-11-06 | 2010-05-14 | Leon Rosenberg | Package of pills useful for titration and method of titrating a patient |
US9248123B2 (en) | 2010-01-11 | 2016-02-02 | Orexigen Therapeutics, Inc. | Methods of providing weight loss therapy in patients with major depression |
US20120145585A1 (en) | 2010-12-08 | 2012-06-14 | Id-Con, Llc | Packaging systems and methods |
US8752704B2 (en) * | 2010-12-17 | 2014-06-17 | The Procter & Gamble Company | Blister cards promoting intuitive dosing |
US9445970B2 (en) | 2010-12-17 | 2016-09-20 | The Procter & Gamble Company | Blister cards promoting intuitive dosing |
US8905237B2 (en) | 2010-12-17 | 2014-12-09 | The Procter & Gamble Company | Blister cards promoting intuitive dosing |
US9351907B2 (en) | 2011-07-19 | 2016-05-31 | Id-Con, Llc | Packaging systems and methods |
JP5942405B2 (en) * | 2011-12-07 | 2016-06-29 | 住友ベークライト株式会社 | Tablet packaging |
PL3730132T3 (en) | 2012-06-06 | 2022-10-10 | Nalpropion Pharmaceuticals Llc | Composition for use in a method of treating overweight and obesity in patients with high cardiovascular risk |
CN103112658A (en) * | 2013-03-08 | 2013-05-22 | 苏州市职业大学 | Bubble cap medicine packaging enabling user to set medicine-taking reminder autonomously |
US10499706B2 (en) | 2013-03-22 | 2019-12-10 | Reebok International Limited | Molded footwear upper and method of making same |
US8969371B1 (en) | 2013-12-06 | 2015-03-03 | Orexigen Therapeutics, Inc. | Compositions and methods for weight loss in at risk patient populations |
MX2017005299A (en) | 2014-10-23 | 2017-07-28 | Arena Pharm Inc | Method of treating conditions related to the pgi2 receptor. |
US10527037B2 (en) | 2016-04-18 | 2020-01-07 | Baker Hughes, A Ge Company, Llc | Mud motor stators and pumps and method of making |
CA3054835A1 (en) | 2017-03-01 | 2018-09-07 | Arena Pharmaceuticals, Inc. | Compositions comprising pgi2-receptor agonists and processes for the preparation thereof |
US11406563B2 (en) | 2018-07-27 | 2022-08-09 | Société des Produits Nestlé S.A. | Oral immunotherapy unit dose dispensing systems and methods |
US11593679B2 (en) * | 2019-11-29 | 2023-02-28 | Kpn Innovations, Llc. | Method of and system for generating a longevity element and an instruction set for a longevity element plan |
WO2022194941A1 (en) * | 2021-03-17 | 2022-09-22 | Actelion Pharmaceuticals Ltd | Pharmaceutical dosage system |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE30331C (en) * | W. H. thompson in London, England | Mills whose storage areas are protected from contamination by the grinding products by flushing with air or water | ||
DE83668C (en) * | ||||
US383668A (en) * | 1888-05-29 | Electrical indicator for alternating electric currents | ||
US2415859A (en) | 1943-05-15 | 1947-02-18 | Ancker Enock | Tablet container and dispenser |
US3099352A (en) | 1961-09-28 | 1963-07-30 | Aven Walter | Calendar reminder and dispensing device |
US3225913A (en) | 1963-09-30 | 1965-12-28 | Laurel M Lee | Capsule and tablet pocket carrier |
US3568828A (en) * | 1967-03-01 | 1971-03-09 | Squibb & Sons Inc | Modified sequential oral contraceptive |
US3494322A (en) * | 1968-04-23 | 1970-02-10 | Bristol Myers Co | Pill dispensing means |
US3738480A (en) | 1971-11-17 | 1973-06-12 | Central Res Labor Inc | Medication container |
US3809221A (en) | 1972-10-10 | 1974-05-07 | N Compere | Rupturable blister pill package with safety backing |
US3826222A (en) | 1973-02-12 | 1974-07-30 | J Romick | Unit-dose medication handling system |
US3921806A (en) | 1974-06-10 | 1975-11-25 | Joyce L Wawracz | Pill dispenser |
US4148273A (en) | 1976-09-07 | 1979-04-10 | Hollingsworth Delbert L | Medicine management device |
US4473884A (en) | 1982-01-08 | 1984-09-25 | Sybron Corporation | Electronic medication dispensing system |
US4706815A (en) * | 1982-08-23 | 1987-11-17 | American Home Products Corporation | Dispensing container for triphasic |
US4473156A (en) | 1982-11-05 | 1984-09-25 | St. Paul-Ramsey Hospital Medical | Method and apparatus for accurately selecting storing and dispensing pills |
US4617557A (en) | 1984-11-08 | 1986-10-14 | National Patent Development Corporation | Medication compliance aid for unit dose packaging |
CA1266179A (en) * | 1986-01-23 | 1990-02-27 | Clovis Poirier | Baiting apparatus |
US4958736A (en) * | 1986-03-18 | 1990-09-25 | Gynex, Inc. | Package for oral contraceptive tablet |
US4889236A (en) * | 1988-02-26 | 1989-12-26 | Warner-Lambert Company | Credit card-style medication package |
US4883180A (en) | 1988-06-09 | 1989-11-28 | Essie Mae Humphrey | Color coded medicine caps and labels for daily dosage |
US4889238A (en) * | 1989-04-03 | 1989-12-26 | The Procter & Gamble Company | Medicament package for increasing compliance with complex therapeutic regimens |
US5752235A (en) * | 1990-01-17 | 1998-05-12 | Informedix, Inc. | Electronic medication monitoring and dispensing method |
USD330331S (en) | 1990-01-26 | 1992-10-20 | Baker Cummins Pharamaceuticals, Inc. | Unit dose drug control package |
US5455279A (en) * | 1991-04-19 | 1995-10-03 | The Children's Medical Center Corporation | Regimen method of mediating neuronal damage using nitroglycerine |
US5922773A (en) * | 1992-12-04 | 1999-07-13 | The Children's Medical Center Corp. | Glaucoma treatment |
US5288107A (en) * | 1993-01-27 | 1994-02-22 | Engineered Data Products, Inc. | Multiple information field label |
USD383668S (en) | 1994-11-01 | 1997-09-16 | Medical Technology Systems, Inc. | Portable electronic medication dispenser |
JP2662206B2 (en) | 1995-07-20 | 1997-10-08 | 日本イーライリリー株式会社 | Tablet container |
US6564945B1 (en) * | 1997-07-14 | 2003-05-20 | Robert E. Weinstein | Medication assemblage for use in sinusitis treatment regimens |
CA2218470A1 (en) | 1997-12-12 | 1999-06-12 | Derek T. Intini | Discreet patient friendly compliance package |
US6047829A (en) * | 1998-09-18 | 2000-04-11 | Westvaco Corporation | Unit dose packaging system (UDPS) having a child resistant locking feature |
US6169707B1 (en) * | 1998-11-30 | 2001-01-02 | Douglas A. Newland | Medication storage and reminder device |
US6375956B1 (en) * | 1999-07-22 | 2002-04-23 | Drugtech Corporation | Strip pack |
US6471645B1 (en) * | 1999-12-30 | 2002-10-29 | Medtronic, Inc. | Communications system for an implantable device and a drug dispenser |
US6411567B1 (en) * | 2000-07-07 | 2002-06-25 | Mark A. Niemiec | Drug delivery management system |
US6651816B2 (en) * | 2001-05-04 | 2003-11-25 | Robert E. Weinstein | Antihistamine/decongestant regimens for treating rhinitis |
US6491211B1 (en) * | 2001-08-03 | 2002-12-10 | Scott & Daniells, Inc. | Child resistant carton and method for using the same |
GB2380937A (en) | 2001-10-18 | 2003-04-23 | David Ian Slovick | Method of dispensing a plurality of medical substances into capsules |
US7086532B2 (en) * | 2003-07-16 | 2006-08-08 | Allergan, Inc. | Titration/compliance pack with increasing doses |
JP2004231588A (en) * | 2003-01-31 | 2004-08-19 | Takeda Chem Ind Ltd | Method for treating neurodegenerative disease or the like |
US20040176381A1 (en) * | 2003-03-06 | 2004-09-09 | Walsh Michael J. | Methotrexate compliance packaging |
RS20050851A (en) * | 2003-05-27 | 2008-04-04 | Forest Laboratories Inc., | Combination of an nmda receptor antagonist and a selective serotonin reuptake inhibitor for the t reatment of depression and other mood disorders |
EP1631273A1 (en) * | 2003-06-16 | 2006-03-08 | Allergan, Inc. | Memantine oral dosage forms |
-
2003
- 2003-07-16 US US10/622,170 patent/US7086532B2/en not_active Expired - Fee Related
-
2004
- 2004-07-09 MX MXPA06000466A patent/MXPA06000466A/en active IP Right Grant
- 2004-07-09 RU RU2006105657/14A patent/RU2006105657A/en not_active Application Discontinuation
- 2004-07-09 WO PCT/US2004/021991 patent/WO2005009326A1/en active Application Filing
- 2004-07-09 KR KR1020067000973A patent/KR20060038998A/en not_active Application Discontinuation
- 2004-07-09 JP JP2006520231A patent/JP2007531541A/en active Pending
- 2004-07-09 CN CNA2004800204893A patent/CN1822808A/en active Pending
- 2004-07-09 PL PL379123A patent/PL379123A1/en unknown
- 2004-07-09 CA CA002532438A patent/CA2532438A1/en not_active Abandoned
- 2004-07-09 BR BRPI0412583-5A patent/BRPI0412583A/en not_active IP Right Cessation
- 2004-07-09 EP EP04756814A patent/EP1643954A1/en not_active Withdrawn
- 2004-07-09 AU AU2004258884A patent/AU2004258884A1/en not_active Abandoned
-
2005
- 2005-12-22 ZA ZA200510420A patent/ZA200510420B/en unknown
-
2006
- 2006-01-05 NO NO20060083A patent/NO20060083L/en not_active Application Discontinuation
- 2006-01-10 IL IL173075A patent/IL173075A0/en unknown
- 2006-05-19 US US11/438,027 patent/US7422110B2/en not_active Expired - Lifetime
- 2006-07-07 US US11/483,039 patent/US7810643B2/en active Active
Non-Patent Citations (1)
Title |
---|
See references of WO2005009326A1 * |
Also Published As
Publication number | Publication date |
---|---|
US7086532B2 (en) | 2006-08-08 |
JP2007531541A (en) | 2007-11-08 |
WO2005009326A1 (en) | 2005-02-03 |
MXPA06000466A (en) | 2006-04-11 |
CN1822808A (en) | 2006-08-23 |
NO20060083L (en) | 2006-02-15 |
US20060278557A1 (en) | 2006-12-14 |
US20050011804A1 (en) | 2005-01-20 |
BRPI0412583A (en) | 2006-09-19 |
RU2006105657A (en) | 2006-08-10 |
US7422110B2 (en) | 2008-09-09 |
US20060231452A1 (en) | 2006-10-19 |
IL173075A0 (en) | 2006-06-11 |
CA2532438A1 (en) | 2005-02-03 |
AU2004258884A1 (en) | 2005-02-03 |
US7810643B2 (en) | 2010-10-12 |
ZA200510420B (en) | 2006-12-27 |
PL379123A1 (en) | 2006-07-10 |
KR20060038998A (en) | 2006-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7422110B2 (en) | Titration/compliance pack with increasing doses | |
US20020066691A1 (en) | Therapy pack | |
US6843372B2 (en) | Antihistamine/decongestant regimens for treating rhinitis | |
US6270796B1 (en) | Antihistamine/decongestant regimens for treating rhinitis | |
US6293403B1 (en) | Vitamin organizing, storing and dispensing system | |
US20140183095A1 (en) | Blister package for patient compliance | |
US7556150B2 (en) | Dispenser for progestin used for acute and maintenance treatment of DUB | |
EP1896022B1 (en) | Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion | |
AU2004226326B2 (en) | Kit for pharmaceutical use | |
WO2021014468A1 (en) | Blister package for improved patient compliance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20060112 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR |
|
DAX | Request for extension of the european patent (deleted) | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1089081 Country of ref document: HK |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: VANDER, ZANDEN, JOHN, JACOB Inventor name: TERWILLIGER, RODNEY |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20081030 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1089081 Country of ref document: HK |